Radiation Therapy Reduced Blood Levels of LDH, HIF-1α, and miR-210 in OSCC

Zhang S, Tian L, Ma P, Sun Q, Zhang K (2015) GuanchaoWang, et al. potential role of differentially expressed lncRNAs in the pathogenesis of oral squamous cell carcinoma. Arch Oral Biol 60(10):1581–1587 Gupta A, Baxi S, Hoyne C (2017) Assessing feasibility, compliance and toxicity of concomitant chemo-radiotherapy in head and neck cancers in the Northern Territory: initial experience and challenges. J Med Radiat Sci 64(2):131–137 Fraga CA, de Oliveira MV, de Oliveira ES, Barros LO, Santos FB, Gomez RS et al (2012) A high HIF-1alpha expression genotype is associated with poor prognosis of upper aerodigestive tract carcinoma patients. Oral Oncol 48(2):130–135 Gruber G, Greiner RH, Hlushchuk R, Aebersold DM, Altermatt HJ, Berclaz G, Djonov V (2004) Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter? Breast Cancer Res : BCR 6(3):R191–R198 Thongchot S, Yongvanit P, Loilome W, Seubwai W, Phunicom K, Tassaneeyakul W, Pairojkul C, Promkotra W, Techasen A, Namwat N (2014) High expression of HIF-1alpha, BNIP3 and PI3KC3: hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis. Asian Pacific journal of Cancer Prevention : APJCP 15(14):5873–5878 Warnakulasuriya S (2009) Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45(4–5):309–316 Stelzle F, Knipfer C, Schuster M, Bocklet T, Nöth E, Adler W, Schempf L, Vieler P, Riemann M, Neukam FW, Nkenke E (2013) Factors influencing relative speech intelligibility in patients with oral squamous cell carcinoma: a prospective study using automatic, computer-based speech analysis. Int J Oral Maxillofac Surg 42(11):1377–1384 Nordsmark M, Bentzen SM, Rudat V, Brizel D, Lartigau E, Stadler P, Becker A, Adam M, Molls M, Dunst J, Terris DJ, Overgaard J (2005) Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 77(1):18–24 Barker HE, Paget JT, Khan AA, Harrington KJ (2015) The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer 15(7):409–425 Guimaraes TA, Farias LC, Santos ES, de Carvalho Fraga CA, Orsini LA, de Freitas TL et al (2016) Metformin increases PDH and suppresses HIF-1alpha under hypoxic conditions and induces cell death in oral squamous cell carcinoma. Oncotarget 7(34):55057–55068 Otto AM (2016) Warburg effect(s)—a biographical sketch of Otto Warburg and his impacts on tumor metabolism. Cancer Metab 4(1):5 Luc R, Tortorella SM, Ververis K, Karagiannis TC (2015) Lactate as an insidious metabolite due to the Warburg effect. Mol Biol Rep 42(4):835–840 Loeffelbein DJ, Eiber M, Mayr P, Souvatzoglou M, Mucke T, von Bomhard A et al (2015) Loco-regional recurrence after surgical treatment of oral squamous cell carcinoma: proposals for follow-up imaging based on literature, national guidelines and institutional experience. J Craniomaxillofac Surg 43(8):1546–1552 Allison SJ, Knight JR, Granchi C, Rani R, Minutolo F, Milner J et al (2014) Identification of LDH-A as a therapeutic target for cancer cell killing via (i) p53/NAD(H)-dependent and (ii) p53-independent pathways. Oncogene 3:e102 Read JA, Winter VJ, Eszes CM, Sessions RB, Brady RL (2001) Structural basis for altered activity of M- and H-isozyme forms of human lactate dehydrogenase. Proteins 43(2):175–185 Fantin VR, St-Pierre J, Leder P (2006) Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9(6):425–434 Semenza GL (1999) Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15:551–578 de Carvalho Fraga CA, Alves LR, Marques-Silva L, de Sousa AA, Jorge AS, de Jesus SF et al (2013) High HIF-1alpha expression genotypes in oral lichen planus. Clin Oral Investig 17(9):2011–2015 Hoffmann AC, Mori R, Vallbohmer D, Brabender J, Drebber U, Baldus SE, Klein E, Azuma M, Metzger R, Hoffmann C, Hoelscher AH, Danenberg KD, Prenzel KL, Danenberg PV (2008) High expression of heparanase is significantly associated with dedifferentiation and lymph node metastasis in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA and via HIF1a to HB-EGF and bFGF. J Gastrointest Surg 12(10):1674–1681 discussion 81-2 Tuomisto A, Garcia-Solano J, Sirnio P, Vayrynen J, Perez-Guillermo M, Makinen MJ et al (2016) HIF-1alpha expression and high microvessel density are characteristic features in serrated colorectal cancer. Virchows Arch 469(4):395–404 van der Groep P, Bouter A, Menko FH, van der Wall E, van Diest PJ (2008) High frequency of HIF-1α overexpression in BRCA1 related breast cancer. Breast Cancer Res Treat 111(3):475–480 Aebersold DM, Burri P, Beer KT, Laissue J, Djonov V, Greiner RH, Semenza GL (2001) Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res 61(7):2911–2916 Silva P, Slevin NJ, Sloan P, Valentine H, Cresswell J, Ryder D, Price P, Homer JJ, West CML (2008) Prognostic significance of tumor hypoxia inducible factor-1alpha expression for outcome after radiotherapy in oropharyngeal cancer. Int J Radiat Oncol Biol Phys 72(5):1551–1559 Langhammer S, Najjar M, Hess-Stumpp H, Thierauch KH (2011) LDH-A influences hypoxia-inducible factor 1alpha (HIF1 alpha) and is critical for growth of HT29 colon carcinoma cells in vivo. Target Oncol 6(3):155–162 Pouyssegur J, Dayan F, Mazure NM (2006) Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441(7092):437–443 Karatas OF, Suer I, Yuceturk B, Yilmaz M, Oz B, Guven G et al (2016) Identification of microRNA profile specific to cancer stem-like cells directly isolated from human larynx cancer specimens. BMC Cancer 16(1):853 Puissegur MP, Mazure NM, Bertero T, Pradelli L, Grosso S, Robbe-Sermesant K et al (2011) miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity. Cell Death Differ 18(3):465–478 Camps C, Buffa FM, Colella S, Moore J, Sotiriou C, Sheldon H, Harris AL, Gleadle JM, Ragoussis J (2008) Hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res 14(5):1340–1348 Gee HE, Camps C, Buffa FM, Patiar S, Winter SC, Betts G, Homer J, Corbridge R, Cox G, West CM, Ragoussis J, Harris AL (2010) Hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer. Cancer 116(9):2148–2158 Fasanaro P, D'Alessandra Y, Di Stefano V, Melchionna R, Romani S, Pompilio G et al (2008) MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem 283(23):15878–15883 Hockel M, Vaupel P (2001) Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93(4):266–276 Okunieff P, Hoeckel M, Dunphy EP, Schlenger K, Knoop C, Vaupel P (1993) Oxygen tension distributions are sufficient to explain the local response of human breast tumors treated with radiation alone. Int J Radiat Oncol Biol Phys 26(4):631–636 Yang X, Zhu H, Ge Y, Liu J, Cai J, Qin Q, Zhan L, Zhang C, Xu L, Liu Z, Yang Y, Yang Y, Ma J, Cheng H, Sun X (2014) Melittin enhances radiosensitivity of hypoxic head and neck squamous cell carcinoma by suppressing HIF-1alpha. Tumor Biol 35(10):10443–10448 Moeller BJ, Dreher MR, Rabbani ZN, Schroeder T, Cao Y, Li CY, Dewhirst MW (2005) Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity. Cancer Cell 8(2):99–110 Liu J, Zhang J, Wang X, Li Y, Chen Y, Li K, Zhang J, Yao L, Guo G (2010) HIF-1 and NDRG2 contribute to hypoxia-induced radioresistance of cervical cancer Hela cells. Exp Cell Res 316(12):1985–1993 Dong G, Chen Q, Jiang F, Yu D, Mao Q, Xia W, Shi R, Wang J, Xu L (2016) Diisopropylamine dichloroacetate enhances radiosensitization in esophageal squamous cell carcinoma by increasing mitochondria-derived reactive oxygen species levels. Oncotarget 7(42):68170–68178 Lall R, Ganapathy S, Yang M, Xiao S, Xu T, Su H, Shadfan M, Asara JM, Ha CS, Ben-Sahra I, Manning BD, Little JB, Yuan ZM (2014) Low-dose radiation exposure induces a HIF-1-mediated adaptive and protective metabolic response. Cell Death Differ 21(5):836–844 Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386 Rosner B (2011) Fundamentals of biostatistics. Brooks/Cole, Cengage Learning, Boston Katabi N, Lewis JS (2017) Update from the 4th edition of the World Health Organization classification of head and neck Tumours: what is new in the 2017 WHO blue book for tumors and tumor-like lesions of the neck and lymph nodes. Head Neck Pathol 11(1):48–54 El-Naggar AK, Chan JKC, Grandis JR, Takata T (2017) Slootweg PJ. WHO Classification of Head and Neck Tumours, International Agency for Research on Cancer Guimaraes TA, Farias LC, Fraga CA, Feltenberger JD, Melo GA, Coletta RD, Souza Santos SH, de Paula AMB, Guimaraes AL (2016) Evaluation of the antineoplastic activity of gallic acid in oral squamous cell carcinoma under hypoxic conditions. Anti-Cancer Drugs 27(5):407–416 Helman LJ, Gazdar AF, Park JG, Cohen PS, Cotelingam JD, Israel MA (1988) Chromogranin a expression in normal and malignant human tissues. J Clin Invest 82(2):686–690 Domingos PLB, Souza MG, Guimaraes TA, Santos ES, Farias LC, de Carvalho Fraga CA et al (2017) Hypoxia reduces the E-cadherin expression and increases OSCC cell migration regardless of the E-cadherin methylation profile. Pathol Res Pract 213(5):496–501 Aragao AZ, Belloni M, Simabuco FM, Zanetti MR, Yokoo S, Domingues RR et al (2012) Novel processed form of syndecan-1 shed from SCC-9 cells plays a role in cell migration. PLoS One 7(8):e43521 Xia J, Wishart DS (2010) MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data. Nucleic Acids Res 38(Web Server issue):W71–W77 Xia J, Sinelnikov IV, Han B, Wishart DS (2015) MetaboAnalyst 3.0--making metabolomics more meaningful. Nucleic Acids Res 43(W1):W251–W257 Vaupel P, Harrison L (2004) Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. Oncologist 9(Suppl 5):4–9 Schneider CA, Rasband WS, Eliceiri KW (2012) NIH image to ImageJ: 25 years of image analysis. Nat Meth 9(7):671–675 Mithani SK, Mydlarz WK, Grumbine FL, Smith IM, Califano JA (2007) Molecular genetics of premalignant oral lesions. Oral Dis 13(2):126–133 Speksnijder CM, van der Glas HW, van der Bilt A, van Es RJ, van der Rijt E, Koole R (2010) Oral function after oncological intervention in the oral cavity: a retrospective study. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 68(6):1231–1237 Coutinho-Camillo CM, Lourenco SV, de Araujo LL, Kowalski LP, Soares FA (2015) Expression of apoptosis-regulating miRNAs and target mRNAs in oral squamous cell carcinoma. Cancer Genet 208(7–8):382–389 Scapoli L, Palmieri A, Lo Muzio L, Pezzetti F, Rubini C, Girardi A et al (2010) MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression. Int J Immunopathol Pharmacol 23(4):1229–1234 Golias T, Papandreou I, Sun R, Kumar B, Brown NV, Swanson BJ, Pai R, Jaitin D, le QT, Teknos TN, Denko NC (2016) Hypoxic repression of pyruvate dehydrogenase activity is necessary for metabolic reprogramming and growth of model tumours. Sci Rep 6:31146 Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC (2006) HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 3(3):187–197 De Saedeleer CJ, Copetti T, Porporato PE, Verrax J, Feron O, Sonveaux P (2012) Lactate activates HIF-1 in oxidative but not in Warburg-phenotype human tumor cells. PLoS One 7(10):e46571 Saito K, Matsumoto S, Takakusagi Y, Matsuo M, Morris HD, Lizak MJ, Munasinghe JP, Devasahayam N, Subramanian S, Mitchell JB, Krishna MC (2015) 13C-MR spectroscopic imaging with hyperpolarized [1-13C]pyruvate detects early response to radiotherapy in SCC tumors and HT-29 tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 21(22):5073–5081 Hosokawa Y, Okumura K, Terashima S, Sakakura Y (2012) Radiation protective effect of hypoxia-inducible factor-1alpha (HIF-1alpha) on human oral squamous cell carcinoma cell lines. Radiat Prot Dosimetry 152(1–3):159–163 Leung E, Cairns RA, Chaudary N, Vellanki RN, Kalliomaki T, Moriyama EH, Mujcic H, Wilson BC, Wouters BG, Hill R, Milosevic M (2017) Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors. BMC Cancer 17(1):418 Koukourakis MI, Giatromanolaki A (2018) Warburg effect, lactate dehydrogenase, and radio/chemo-therapy efficacy. Int J Radiat Biol:1–19. https://doi.org/10.1080/09553002.2018.1490041 Jackson SP, Bartek J (2009) The DNA-damage response in human biology and disease. Nature 461(7267):1071–1078 Demaria S, Ng B, Devitt ML, Babb JS, Kawashima N, Liebes L, Formenti SC (2004) Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Int J Radiat Oncol Biol Phys 58(3):862–870 Le A, Cooper CR, Gouw AM, Dinavahi R, Maitra A, Deck LM et al (2010) Inhibition of lactate dehydrogenase a induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci U S A 107(5):2037–2042 Serganova I, Cohen IJ, Vemuri K, Shindo M, Maeda M, Mane M, Moroz E, Khanin R, Satagopan J, Koutcher JA, Blasberg R (2018) LDH-A regulates the tumor microenvironment via HIF-signaling and modulates the immune response. PLoS One 13(9):e0203965 Herskind C, Ma L, Liu Q, Zhang B, Schneider F, Veldwijk MR, Wenz F (2017) Biology of high single doses of IORT: RBE, 5 R's, and other biological aspects. Radiat Oncol 12(1):24 Dewan MZ, Galloway AE, Kawashima N, Dewyngaert JK, Babb JS, Formenti SC, Demaria S (2009) Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. Clinical cancer research : an official journal of the American Association for Cancer Research. 15(17):5379–5388 Golden EB, Chhabra A, Chachoua A, Adams S, Donach M, Fenton-Kerimian M, Friedman K, Ponzo F, Babb JS, Goldberg J, Demaria S, Formenti SC (2015) Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial. Lancet Oncol 16(7):795–803